文献速递胸部病理细胞病理与分子病理

肿瘤细胞密度数字化定量作为非小细胞肺癌新型预后特征

Digital Quantification of Tumor Cellularity as a Novel Prognostic Feature of Non-Small Cell Lung Carcinoma.
PubMed 文献 · Mod Pathol · 2023-01-10

研究利用QuPath对TCGA肺腺癌(n=213)和肺鳞癌(n=90)数字切片分析,计算肿瘤细胞密度与细胞总数。结果显示高级别组织学模式对应更高肿瘤密度,低细胞密度患者总生存与无进展生存更优,提示肿瘤细胞密度可作为非小细胞肺癌新型预后工具。

要点

  • 高级别组织学模式与更高肿瘤细胞密度相关。
  • 低肿瘤细胞密度患者总生存与无进展生存更优。
  • 肿瘤细胞密度可作为结合分期与分级的预后工具。

核心结论

  • 肿瘤细胞密度数字化定量可作为非小细胞肺癌的新型预后工具,兼顾肿瘤分期与分级要素。

研究设计与样本

  • 回顾性分析TCGA肺腺癌数据集(n=213)和肺鳞癌数据集(n=90)的数字切片,使用QuPath进行数字化图像分析。

主要发现

  • 肺腺癌和肺鳞癌病例中,高级别组织学模式相比低级别模式与更高肿瘤密度相关。
  • 低肿瘤细胞密度病例相比高细胞密度病例,总生存与无进展生存均更优。

关键数值与推荐

  • 肿瘤细胞数量以肿瘤表面积归一化得到肿瘤细胞密度,肿瘤细胞密度由肿瘤大小乘以细胞密度计算。

临床怎么用

  • 可借助数字化图像分析工具量化肿瘤细胞密度,辅助非小细胞肺癌预后评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Non-small cell lung carcinoma is currently staged based on the size and involvement of other structures. Tumor size may be a surrogate measure of the total number of tumor cells. A recently revised reporting system for adenocarcinoma incorporates high-risk histologic patterns, which may have increased cellular density. Modern digital image analysis tools can be utilized to automate the quantification of cells. In this study, we tested the hypothesis that tumor cellularity can be used as a novel prognostic tool for lung cancer. Digital slides from The Cancer Genome Atlas lung adenocarcinoma (ADC) data set (n = 213) and lung squamous cell carcinoma (SCC) data set (n = 90) were obtained and analyzed using QuPath. The number of tumor cells was normalized with the surface area of the tumor to provide a measure of tumor cell density. Tumor cellularity was calculated by multiplying the size of the tumor with the cell density. Major histologic patterns and grade were compared with the tumor density of the lung ADC and lung SCC cases. The overall and progression-free survival were compared between groups of high and low tumor cellularity. High-grade histologic patterns in the ADC and SCC cases were associated with greater tumor densities compared with low-grade patterns. Cases with lower tumor cellularity had improved overall and progression-free survival compared with cases with higher cellularity. These results support tumor cellularity as a novel prognostic tool for non-small cell lung carcinoma that considers tumor stage and grade elements.

来源:Mod Pathol,查看原文。版权归原作者所有。

引用

  1. Lin S, Samsoondar JP, Bandari E, et al. Digital Quantification of Tumor Cellularity as a Novel Prognostic Feature of Non-Small Cell Lung Carcinoma. Mod Pathol. 2023. PMID: 36788101. doi:10.1016/j.modpat.2022.100055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。